Article Text

Download PDFPDF
CASE REPORT
Pneumomediastinum secondary to mephedrone inhalation
  1. Chris McCullough1,
  2. Margaret Geraldine Keane2,
  3. Toby Hillman3,
  4. Samer Elkhodair1
  1. 1Department of Emergency Medicine, University College Hospital, London, UK
  2. 2Institute for Liver and Digestive Health, University College London, London, UK
  3. 3The London Chest Hospital, London, UK
  1. Correspondence to Dr Chris McCullough, chris.mccullough{at}nhs.net

Summary

A 23-year-old man presented to the emergency department with severe, central, pleuritic chest pain. The pain was present on waking and exacerbated by movement. On examination, supraclavicular and anterior chest wall surgical emphysema was noted, otherwise examination and initial observations were normal. A chest x-ray and subsequent chest CT demonstrated a pneumomediastium with significant subcutaneous emphysema. There was no history of vomiting or chest trauma, but the patient had inhaled mephedrone, a synthetic stimulant drug, 36 h prior. Pneumomediastinum is an uncommon complication of inhalational drug use.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.